文档介绍：MORGAN STANLEY RESEARCH
Morgan Stanley & Co.
MARCH 24, 2010
NorthNorth HIGHLIGHTS
AmericaAmerica
23 Healthcare Svcs. & Distribution
INVESTMENT Upgrade MCK on Growth
Prospects; Downgrade DGX, LH
PERSPECTIVES on Lack of Catalysts
Ricky R. Goldwasser et al.
39 o Menthol: FDA Advisory
Panel Likely to Focus on Soft
Issues, Not Relative Risk
David J. Adelman et al.
43 Coach We’re Buyers of COH
Heading into 3Q Results April 20
Michelle L. Clark et al.
Strategy and Economics 19 Currency Strategy Currency Politics Heating Up
Sophia Drossos
3 Morgan Stanley Best Ideas List
21 mentary Behind the Spreadsheet:
7 US Economics The Rebirth of Pricing Power
The Handset Wars (Simon Flannery/Ehud
Richard Berner
Gelblum/Katy Huberty/Mary Meeker), Part I
9 US Credit Strategy Performance BBooster Douglas M. Cohen
Rizwan Hussain, Adam Richmond, Jocelyn Chu
Opinion Changes
11 Global Equity Strategy
Permanently Higher Plateau? 23 Healthcare Services & Distribution
Gerard Minack, Jason Todd MCK Upgraded on Growth Prospects;
DGX and LH Downgraded on Lack of Catalysts
13 UK Equity Strategy
Ricky R. Goldwasser, Hema Srinivasan, Andrew Schenker
Why EM Trade Has Further to Run
Graham Secker, Catharina Luebke-Detring New Coverage
15 China Equity Strategy A Revisit to Rmb 25 Freight Transportation
Revaluation’s Market Implications Freight Forwarders: Too Early To Go Late Cycle;
Jerry Lou, Allen Gui We Prefer UTIW to EXPD
17 Equity Derivative Strategy The Short Volatility William J. Greene, Adam Longson
Trade – From Cyclical to Carry (continued)
Sivan Mahadevan, Christopher Metli et al.
Morgan Stanley does and seeks to do business panies covered in its research reports. As a result,
investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report.
Investors should consider this report as only a single